METTL3 and chronic obstructive pulmonary disease: It provides a new direction for the study of the mechanism of COPD, identifies key molecules such as METTL3 and IGF2BP3, and lays a foundation for the development of COPD treatment strategies targeting m6A modification or NRF2 pathway.